ImmunoPrecise Antibodies (IPA) has released an update.
ImmunoPrecise Antibodies Ltd. has announced its upcoming annual general meeting on November 14, 2024, where shareholders will review financial statements, elect directors, and appoint auditors. The meeting will be conducted via live webcast, allowing registered shareholders to participate and vote remotely. This event is crucial for stakeholders as it outlines the company’s governance and future strategy.
For further insights into IPA stock, check out TipRanks’ Stock Analysis page.
